Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population
- PMID: 24966617
- PMCID: PMC4064092
- DOI: 10.3748/wjg.v20.i23.7466
Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population
Abstract
Aim: To explore the association of MYO9B gene polymorphisms with clinical phenotypes and intestinal permeability of individuals with inflammatory bowel disease (IBD) in China.
Methods: A total of 442 IBD patients and 402 healthy volunteers were genotyped for two single nucleotides (rs962917 and rs1545620) using the ligase detection reaction and polymerase chain reaction. Allelic and genotype frequency analyses were performed for the two groups. Intestinal permeability was evaluated using lactulose (L) and mannitol (M) excretion. The association of MYO9B gene polymorphisms with intestinal permeability between the normal and high intestinal permeability groups was analyzed.
Results: Overall, there was no significant difference in the genotypic and allelic frequencies of MYO9B between IBD patients and controls. Although no association was found with ulcerative colitis in the comparison between the subgroups, the frequencies of rs962917 and rs1545620 were different in the Crohn's disease (CD) subgroup with ileocolitis (CC vs CT and TT, P = 0.014; and AA vs AC and CC, P = 0.022, respectively). rs1545620 variants appear to be the genetic susceptibility factor for perianal disease in CD patients (AA vs AC CC, P = 0.029). In addition, the L/M ratio was significantly higher in IBD patients than in controls (0.065 ± 0.013 vs 0.020 ± 0.002, P = 0.02), but no association was found between the MYO9B gene and the L/M ratio in IBD patients.
Conclusion: MYO9B gene polymorphisms may influence the sub-phenotypic expression of CD in China. No association between these MYO9B polymorphisms and intestinal permeability in IBD patients was found.
Keywords: Crohn’s disease; Genetic susceptibility; Inflammatory bowel disease; Intestinal permeability; MYO9B; Ulcerative colitis.
Similar articles
-
The association of MYO9B gene in Italian patients with inflammatory bowel diseases.Aliment Pharmacol Ther. 2008 Feb 1;27(3):241-8. doi: 10.1111/j.1365-2036.2007.03551.x. Epub 2007 Oct 15. Aliment Pharmacol Ther. 2008. PMID: 17944996
-
Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: a study in Crohn's disease.Scand J Gastroenterol. 2014 Oct;49(10):1191-200. doi: 10.3109/00365521.2014.928903. Epub 2014 Aug 6. Scand J Gastroenterol. 2014. PMID: 25098938
-
Replication of genetic variation in the MYO9B gene in Crohn's disease.Hum Immunol. 2011 Jul;72(7):592-7. doi: 10.1016/j.humimm.2011.03.025. Epub 2011 Apr 12. Hum Immunol. 2011. PMID: 21515326
-
Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.World J Gastroenterol. 2013 Oct 21;19(39):6656-64. doi: 10.3748/wjg.v19.i39.6656. World J Gastroenterol. 2013. PMID: 24151396 Free PMC article. Review.
-
Candidate polymorphisms and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis.Gene. 2020 Aug 30;753:144814. doi: 10.1016/j.gene.2020.144814. Epub 2020 May 26. Gene. 2020. PMID: 32464244
Cited by
-
MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases.Oncotarget. 2016 Sep 13;7(37):58862-58875. doi: 10.18632/oncotarget.11186. Oncotarget. 2016. PMID: 27556856 Free PMC article.
-
The Correlation Between MYO9B Gene Polymorphism and Inflammatory Bowel Disease in the Guangxi Zhuang Population.Int J Gen Med. 2021 Dec 1;14:9163-9172. doi: 10.2147/IJGM.S338142. eCollection 2021. Int J Gen Med. 2021. PMID: 34880655 Free PMC article.
References
-
- Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429. - PubMed
-
- Scaldaferri F, Fiocchi C. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis. 2007;8:171–178. - PubMed
-
- Siminovitch KA. Advances in the molecular dissection of inflammatory bowel disease. Semin Immunol. 2006;18:244–253. - PubMed
-
- Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous